Navigation Links
Campbell Alliance to Release New Forward-Looking Industry Report on Deal-Making Trends at the 2013 BIO International Convention
Date:4/19/2013

ven in the face of different commercial projections."

Specifically for in-licensers, 2013 may be a great time to pursue early-stage oncology assets, while they can expect to face competition for clinical-stage and marketed oncology assets.  Similarly, early-stage antibiotic and dermatology assets are relative buyers' markets.  Other therapeutic areas are relative sellers' markets and must be approached with due consideration.  It is important for in-licensers to remain objective in valuing assets and to carefully weigh the organizational fit of assets under consideration.

"For out-licensers, the market appears to be shifting in their favor," added Stewart. "To turn this positive outlook into successful deals, however, out-licensers will need to provide more pricing and market access justification in their non-confidential materials and bridge the valuation gap through credible validation of the commercial opportunity."

A summary of the study results will be presented during a Super Session at the BIO International Convention on Wednesday, April 24 at 2:00pm CT, followed by a panel discussion involving senior industry executives. Panelists for this Super Session will include:

  • William Hait , MD, PhD – Global Head, Janssen Research & Development LLC, Janssen
  • Bahija Jallal , PhD – Executive Vice President, R&D, MedImmune
  • John Leonard , MD – Senior Vice President, Chief Scientific Officer, AbbVie
  • Roger Pomerantz – Worldwide Head of Licensing & Acquisitions, Senior Vice President, Merck Research Labs
  • Chihiro Yokota , RPh – Corporate Executive, Global Head, Business Development and Licensing & Alliances, Astellas Pharma Inc.

Additiona
'/>"/>

SOURCE Campbell Alliance
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Campbell Alliance Launches Market Research and Analytics Group, Appoints Michael Turner as General Manager of Encuity Research
2. SoundConnect Announces New Not-For-Profit Customer in Smart Card Alliance
3. Alliance to Feed the Future Congratulates Our Farmers, Supports Education for Future Generations on National Agriculture Day
4. The Alliance for Regenerative Medicine forms Tissue Engineering and Biomaterials Committee
5. China Cord Blood Corporation and Cordlife Group Limited Foster Closer Alliance Across Asia
6. BioPower Operations Corporation Announces that FTZ Exchange Signs Strategic Alliance with Capacity 360, LLC and Tom Settineri
7. Ekahau - A Preferred Provider of Real-Time Location Solutions - Is Awarded an Agreement with the Premier Healthcare Alliance
8. iBio, Inc. and GE Healthcare form new global alliance
9. Afraxis and PsychoGenics Form Alliance to Offer Afraxis ESP Technology for Drug Discovery
10. Genomind to Participate in National Alliance on Mental Illness (NAMI) 2012 National Convention
11. Clean Energy Alliance and the Manufacturing Extension Partnership Announce New Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 23, 2014 Sigma-Aldrich Corporation (NASDAQ: ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... on December 22, 2014, thereby completing the U.S. ... the acquisition of the Company by Merck KGaA, ... satisfies another condition to closing the transaction, which ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 The ... global leader of technical training across the life sciences ... Data Management (SCDM) to provide the organization's members ... programs —providing access to the more than 350 sessions ... members with 10% off when registering for a ...
(Date:12/22/2014)... 22, 2014  Alternative Energy & Environmental Solutions, ... signed a letter of intent to acquire BioTechPharma ... patented a nanotechnology-based development platform used to create ... rapid on-site collection and testing to identify infectious ... in an immediate, non-invasive and cost-effective manner. ...
(Date:12/22/2014)... December 22, 2014 The ... publication of original research, reviews and editorials addressing ... clinical practice, today published a provocative article exploring ... development, progression and potential treatment of prostate cancer. ... research and proposes the possibility that there could ...
Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3ALNE Announces Intention To Acquire BioTechPharma 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4
... Dec. 14 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis,(ASX: PXS; Nasdaq: PXSL) ... and distribute its asthma diagnostic tool, Aridol in ... European countries included in the,successful mutual recognition procedure ... Alan Robertson., "Bronchial challenge testing is a ...
... Non-surgical, spinal decompression is,probably the last back ... can,forget about popping toxic pills, struggling through exercise,programs...and...unnecessary ... - for most people - they are a ... Chicagoland,s most respected authority on relieving,severe back and ...
... a leader in the field of,sleep diagnostic software ... agreement with the Beth Israel Deaconess Medical Center ... (CPC) technology,developed by Drs. Robert Thomas, Ary Goldberger, ... represents a breakthrough in how sleep can be,visualized, ...
Cached Biology Technology:Pharmaxis Appoints Portuguese Distributor for Aridol 2Amazing Treatment Relieves Serious Back Pain Without Dangerous Drugs, Injections or Surgery! 2Embla Systems in Collaboration with Beth Israel Deaconess Medical Center to Develop Cardio-Pulmonary Coupling Technology 2
(Date:12/10/2014)... , December 9, 2014 ... ITN,s BCARD Platform   ... enterprise meeting scheduling solutions for business-to-business (B2B) events, ... world leader in mobile near-field communication (NFC), Bluetooth ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow ...
(Date:12/3/2014)... -- As part of our commitment to offering the ... announce the release of a new reader that will ... data that they need. The Atlas 2000 ... readers. Many such devices have serious shortcomings when it ... models force users to navigate numerous complicated steps in ...
(Date:11/21/2014)... SAN JOSE, Calif. , Nov. 20, 2014 /PRNewswire/ ... a global leader in microcontroller (MCU) and touch technology ... digital temperature sensors with the widest V ... family delivers higher temperature accuracy and faster I 2 ... nonvolatile registers and serial EEPROM memory making them ideal ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Inception Technologies to Release New Biometric Reader 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
... Life Sciences has opened up a new path to produce water ... drought resistance, and ensure global food security. The research not ... that appears to be the principal gateway for water intake during ... it appears much of the research to date was focussed on ...
... and Technology Directorate,s Fifth Annual University Summit will ... March 30-April 1 2011. This event is ... by university scientists, government officials and industry. ... DHS high-priority research areas with DHS components, industry, ...
... 2011 (BRONX, NY) Ertuğrul zbudak, Ph.D. , ... College of Medicine of Yeshiva University, has won a ... for his research into the genetic causes of vertebral malformations ... and adult diseases, including scoliosis, disfigurement, and back and neck ...
Cached Biology News:New path to water efficient seeds opens as TIP pips PIP as water gatekeeper 2DHS Science and Technology Directorate's science conference: 'Catastrophes and Complex Systems' 2DHS Science and Technology Directorate's science conference: 'Catastrophes and Complex Systems' 3DHS Science and Technology Directorate's science conference: 'Catastrophes and Complex Systems' 4Albert Einstein College of Medicine geneticist wins Sloan Research Fellowship 2
Goat polyclonal to MLH3 Immunogen: Synthetic peptide: RQSLQQSMPPCEPP (Human) from C Terminus of the protein sequence according to NP_055196....
Rabbit polyclonal to NMDAR1 e/f/g/h ( Abpromise for all tested applications)....
Polyclonal Antibody to Coronin / CORO1C This antibody was developed against synthetic peptides corresponding to amino acids 407-420 of human CORO1C....
Peptide-affinity Purified Polyclonal Antibody to Retinoic Acid-Induced 3 (RAI3/RAIG1)...
Biology Products: